IndraLab

Statements



reach
"Next, we tested several small molecule inhibitors targeting NFkB signaling at different stages and identified that BMS345541 (Inhibitor of IKKbeta at IC50 0.4 muM and IKKalpha at IC50 4muM) inhibits GD2 and GD3S expression in TNBC cells [XREF_BIBR]."

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available

No evidence text available